Effect of miR-18a overexpression on the radiosensitivity of non-small cell lung cancer

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 1, 2015, Pages 643-648

  Shen, Zetian ^a   Wu, Xinhu ^a   Wang, Zhen ^a   Li, Bing ^a   Zhu, Xixu ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

Lung cancer; MicroRNA; miR 18a; NSCLC; Radiosensitivity

Indexed keywords

MICRORNA; MIRN18 MICRORNA, HUMAN;

ADULT; AGED; FEMALE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HUMAN; LUNG TUMOR; MALE; MIDDLE AGED; NON SMALL CELL LUNG CANCER; RADIATION DOSE; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; RADIATION TOLERANCE; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFECTION;

EID: 84923088046     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014; 64: 9-29.
2. Webb S. Advances in three-dimensional conformal radiation therapy physics with intensity modulation. Lancet Oncol 2000; 1: 30-36.
3. Hennon MW, Yendamuri S. Advances in lung cancer surgery. J Carcinog 2012; 11: 21.
4. Saadeddin A. Radiotherapy for NSCLC: review of conventional and new treatment techniques. J Infect Public Health 2012; 5: S45-49.
5. Joubert A, Foray N. [Intrinsic radiosensitivity and DNA double-strand breaks in human cells]. Cancer Radiother 2007; 11: 129-142.
6. Ding J, Miao ZH, Meng LH, Geng MY. Emerging cancer therapeutic opportunities target DNA-repair systems. Trends Pharmacol Sci 2006; 27: 338-344.
7. Hinz JM, Yamada NA, Salazar EP, Tebbs RS, Thompson LH. Influence of double-strand-break repair pathways on radiosensitivity throughout the cell cycle in CHO cells. DNA Repair 2005; 4: 782-792.
8. Del Vescovo V, Grasso M, Barbareschi M, Denti MA. MicroRNAs as lung cancer biomarkers. World J Clin Oncol 2014; 5: 604-620.
9. Zhang Y, Yang Q, Wang S. MicroRNAs: a new key in lung cancer. CancerChemother Pharmacol 2014; [Epub ahead of print].
10. Mairinger FD, Ting S, Werner R, Walter RF, Hager T, Vollbrecht C, Christoph D, Worm K, Mairinger T, Sheu-Grabellus SY, Theegarten D, Schmid KW, Wohlschlaeger J. Different micro-RNA expression profiles distinguish subtypes of neuroendocrine tumors of the lung: results of a profiling study. Mod Pathol 2014; [Epub ahead of print].
11. Chatterjee S, Willis N, Locks SM, Mott JH, Kelly CG. Dosimetric and radiobiological comparison of helical tomotherapy, forward-planned intensity-modulated radiotherapy and two-phase conformal plans for radical radiotherapy treatment of head and neck squamous cell carcinomas. Br J Radiol 2011; 84: 1083-1090.
12. Joubert A, Vogin G, Devic C, Granzotto A, Viau M, Maalouf M, Thomas C, Colin C, Foray N. [Radiation biology: major advances and perspectives for radiotherapy]. Cancer Radiotherapie 2011; 15: 348-354.
13. Deng X, Ma L, Wu M, Zhang G, Jin C, Guo Y, Liu R. miR-124 radiosensitizes human glioma cells by targeting CDK4. J Neurooncol 2013; 114: 263-274.
14. Babar IA, Czochor J, Steinmetz A, Weidhaas JB, Glazer PM, Slack FJ. Inhibition of hypoxia-induced miR-155 radiosensitizes hypoxic lung cancer cells. Cancer Biol Ther 2011; 12: 908-914.
15. Li G, Wang Y, Liu Y, Su Z, Liu C, Ren S, Deng T, Huang D, Tian Y, Qiu Y. miR-185-3p regulates nasopharyngeal carcinoma radioresistance by targeting WNT2B in vitro. Cancer Sci 2014; [Epub ahead of print].
16. O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT. c-Myc-regulated microRNAs modulate E2F1 expression. Nature 2005; 435: 839-843.
17. Strickertsson JA, Rasmussen LJ, Friis-Hansen L. Enterococcus faecalis Infection and Reactive Oxygen Species Down-Regulates the miR-17-92 Cluster in Gastric Adenocarcinoma Cell Culture. Genes 2014; 5: 726-738.
18. Liao YC, Lin TH, Chen CY, Lin SB, Au LC. The antileukemia activity of natural product HQ17(3) is possibly associated with downregulation of miR-17-92 cluster. BioMed Res Int 2014; 2014: 306718.
19. Arabi L, Gsponer JR, Smida J, Nathrath M, Perrina V, Jundt G, Ruiz C, Quagliata L, Baumhoer D. Upregulation of the miR-17-92 cluster and its two paraloga in osteosarcoma - reasons and consequences. Genes Cancer 2014; 5: 56-63.
20. Greenberg E, Hajdu S, Nemlich Y, Cohen R, Itzhaki O, Jacob-Hirsch J, Besser MJ, Schachter J, Markel G. Differential regulation of aggressive features in melanoma cells by members of the miR-17-92 complex. Open Biol 2014; 4: 140030.
21. Jin L, Lim M, Zhao S, Sano Y, Simone BA, Savage JE, Wickstrom E, Camphausen K, Pestell RG, Simone NL. The metastatic potential of triple-negative breast cancer is decreased via caloric restriction-mediated reduction of the miR-17∼92 cluster. Breast Cancer Res Treat 2014; 146: 41-50.
22. Krysan K, Kusko R, Grogan T, O'Hearn J, Reckamp KL, Walser TC, Garon EB, Lenburg ME, Sharma S, Spira AE, Elashoff D, Dubinett SM. PGE2-driven expression of c-Myc and oncomiR-17-92 contributes to apoptosis resistance in NSCLC. Mol Cancer Res 2014; 12: 765-774.